Insider · CIK 0001854032
Paul D Bloom
Files at GEVO (Gevo, Inc.). First filing Oct 21, 2024, latest Sep 4, 2026.
In brief
Paul D Bloom files SEC Form 4 as CEO and director at GEVO (Gevo, Inc.). Since Oct 21, 2024, Paul D Bloom has reported 0 open-market buys worth $0 and 10 open-market sells worth $635k, the latest filed on Sep 4, 2026.
A track record needs three past buys with six months of prices behind them; Paul D Bloom has 0, so none is measured yet.
The newest scored trade: sold $2,589 of GEVO on Sep 3, 2026, filed Sep 4, 2026, scored 20 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $234k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GEVO: Gevo, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Gevo, Inc. | $2,589 1,514 shares | -0% | - | |
| 27Weak | Gevo, Inc. | $48k 31,096 shares | -2% | +25% from low-48% from high | |
| 27Weak | Gevo, Inc. | $50k 35,189 shares | -2% | +22% from low-50% from high | |
| 31Weak | Gevo, Inc. | $133k 75,735 shares | -5% | +62% from low-35% from high | |
| 21Weak | Gevo, Inc. | $150k 75,000 shares | -8% | +101% from low-38% from high | |
| 10Weak | Gevo, Inc. | $3,410 2,092 shares | -0% | +120% from low-50% from high | |
| 17Weak | Gevo, Inc. | $52k 42,073 shares | -4% | +66% from low-63% from high | |
| 16Weak | Gevo, Inc. | $35k 27,744 shares | -3% | +65% from low-63% from high | |
| 20Weak | Gevo, Inc. | $112k 87,466 shares | -9% | +72% from low-61% from high | |
| 2Weak | Gevo, Inc. | $49k 16,000 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 3, 2026 | GEVO Gevo, Inc. | 1,514 0.00% of outstanding | $2,589 | Sep 3, 2026 | $98k |
| Aug 6, 2026 | GEVO Gevo, Inc. | 31,096 0.01% of outstanding | $48k | Aug 6, 2026 | $189k |
| Jun 12, 2026 | GEVO Gevo, Inc. | 35,189 0.01% of outstanding | $50k | Jun 12, 2026 | $139k |
| May 27, 2026 | GEVO Gevo, Inc. | 75,735 0.03% of outstanding | $133k | May 27, 2026 | none |
| Sep 17, 2025 | GEVO Gevo, Inc. | 225,000 0.09% of outstanding | $451k | Sep 17, 2025 | $97k |
| Sep 4, 2025 | GEVO Gevo, Inc. | 2,092 0.00% of outstanding | $3,411 | Sep 4, 2025 | $93k |
| Aug 5, 2025 | GEVO Gevo, Inc. | 42,073 0.02% of outstanding | $51k | Aug 5, 2025 | $154k |
| Aug 1, 2025 | GEVO Gevo, Inc. | 33,155 0.01% of outstanding | $43k | Aug 1, 2025 | $112k |
| May 30, 2025 | GEVO Gevo, Inc. | 87,466 0.04% of outstanding | $112k | May 30, 2025 | none |
| Oct 17, 2024 | GEVO Gevo, Inc. | 16,000 0.01% of outstanding | $36k | Oct 17, 2024 | $77k |
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -1,514 | $1.71 | $2,589 | 1,500,789 | 39 d ago |
| Aug 13, 2026 | GEVO Gevo, Inc. | MOption exercise Common Stock | +50,000 | $1.18 | $59k | 1,502,303 | Aug 13, 2026 |
| Aug 13, 2026 | GEVO Gevo, Inc. | MOption exercise Stock Optionderivative | -50,000 | $0.00 | $0 | 576,618 | Aug 13, 2026 |
| Aug 6, 2026 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -31,096 | $1.55 | $48k | 1,452,303 | Aug 7, 2026 |
| Jun 12, 2026 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -35,189 | $1.43 | $50k | 1,483,399 | Jun 15, 2026 |
| May 27, 2026 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -75,735 | $1.76 | $133k | 1,518,588 | May 29, 2026 |
| May 20, 2026 | GEVO Gevo, Inc. | AGrant or award Common Stock | +670,732 | $0.00 | $0 | 1,594,323 | May 22, 2026 |
| May 20, 2026 | GEVO Gevo, Inc. | AGrant or award Stock Optionderivative | +774,967 | $0.00 | $0 | 774,967 | May 22, 2026 |
| Sep 17, 2025 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -75,000 | $2.01 | $150k | 923,591 | Sep 18, 2025 |
| Sep 4, 2025 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -2,092 | $1.63 | $3,410 | 998,591 | Sep 5, 2025 |
| Aug 5, 2025 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -42,073 | $1.23 | $52k | 1,000,683 | Aug 6, 2025 |
| Aug 1, 2025 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -27,744 | $1.25 | $35k | 1,042,756 | Aug 4, 2025 |
| Jun 9, 2025 | GEVO Gevo, Inc. | AGrant or award Common Stock | +210,084 | $0.00 | $0 | 1,070,500 | Jun 11, 2025 |
| Jun 9, 2025 | GEVO Gevo, Inc. | AGrant or award Stock Optionderivative | +626,618 | $0.00 | $0 | 626,618 | Jun 11, 2025 |
| May 30, 2025 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -87,466 | $1.28 | $112k | 860,416 | Jun 2, 2025 |
| Oct 17, 2024 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -16,000 | $3.06 | $49k | 947,882 | Oct 21, 2024 |
Questions about Paul D Bloom
Answered from the filings on this page, as of the latest one.
Is Paul D Bloom buying or selling?
In the last 12 months Paul D Bloom reported 0 open-market buys worth $0 and 4 open-market sells worth $234k on SEC Form 4; the latest was sold $2,589 of GEVO on Sep 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Paul D Bloom's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul D Bloom has 0.
Where does Paul D Bloom file Form 4?
Paul D Bloom has filed Form 4 at GEVO (Gevo, Inc.) as CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.